Filing Details
- Accession Number:
- 0001179110-14-009022
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-23 10:26:28
- Reporting Period:
- 2014-05-21
- Filing Date:
- 2014-05-23
- Accepted Time:
- 2014-05-23 10:26:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1274057 | Hospira Inc | HSP | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1372882 | E Thomas Werner | C/O Hospira, Inc. 275 North Field Drive Lake Forest IL 60045 | Svp, Finance & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-05-21 | 30,000 | $22.15 | 84,614 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-05-21 | 30,000 | $47.98 | 54,614 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (right to buy) | Disposition | 2014-05-21 | 30,000 | $0.00 | 30,000 | $22.15 |
Common Stock | Phantom Shares | Acquisiton | 2014-05-21 | 665 | $0.00 | 665 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
29,566 | 2016-03-04 | No | 4 | M | Direct | |
665 | No | 4 | A | Direct |
Footnotes
- Exercise of derivative security exempted pursuant to Rule 16b-3.
- The stock options vest in four equal annual installments on March 5, 2010, 2011, 2012 and 2013. The exercise price of $47.975 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.82 to $48.16, inclusive. The reporting person undertakes to provide to the company, any security holder of the company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote.
- These phantom shares were acquired under Hospira's Non-Qualified Savings and Investment Plan, a non-qualified deferred compensation plan. Each share of phantom stock is the economic equivalent of one share of common stock. The vested shares of phantom stock become payable in cash upon the earlier of a date specified by the reporting person, change in control, or his separation from service, death or disability.